Susquehanna International Group, LLP Eyenovia, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Eyenovia, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 71,318 shares of EYEN stock, worth $124,093. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,318

Previous 29,904 138.49%

Holding current value

$124,093

Previous $15,000 33.33%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.08 - $0.57 $3,313 - $23,605	41,414 Added 138.49%	71,318 $10,000
Q3 2024 Nov 14, 2024	SELL	$0.46 - $1.44 $26,423 - $82,716	-57,442 Reduced 65.76%	29,904 $15,000
Q2 2024 Aug 15, 2024	BUY	$0.52 - $1.06 $30,414 - $61,999	58,490 Added 202.7%	87,346 $51,000
Q1 2024 May 07, 2024	SELL	$0.99 - $2.37 $60,377 - $144,539	-60,987 Reduced 67.88%	28,856 $28,000
Q4 2023 Feb 14, 2024	BUY	$1.08 - $2.08 $97,030 - $186,873	89,843 New	89,843 $186,000
Q2 2023 Aug 11, 2023	BUY	$2.21 - $5.75 $34,732 - $90,367	15,716 New	15,716 $37,000
Q4 2022 Feb 14, 2023	SELL	$1.54 - $2.74 $55,158 - $98,138	-35,817 Reduced 74.45%	12,289 $20,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.48 $74,564 - $119,302	48,106 New	48,106 $94,000
Q2 2022 Aug 15, 2022	SELL	$1.71 - $3.26 $30,612 - $58,360	-17,902 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.66 - $3.99 $90,075 - $135,113	-33,863 Reduced 65.42%	17,902 $55,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $6.58 $103,033 - $193,702	29,438 Added 131.85%	51,765 $207,000
Q3 2021 Nov 15, 2021	BUY	$3.97 - $5.64 $88,638 - $125,924	22,327 New	22,327 $109,000

Others Institutions Holding EYEN

# of Institutions

Shares Held

5.68M

Call Options Held

72.9K

Put Options Held

36.3K

View Full List

About EYENOVIA, INC.

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $59.5M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

More about EYEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Eyenovia, Inc. Transaction History